To investigate immune checkpoint function in pancreatic cancer, we investigated the MAPK and PI-3K/AKT pathways and observed increased levels of ERK phosphorylation but not AKT phosphorylation when PDAC cells were exposed to PD-L1. Here, AKT1 is linked to pancreatic neoplasm.